Trident Texofab Limited

BSE:540726 Stock Report

Market Cap: ₹607.0m

Trident Texofab Past Earnings Performance

Past criteria checks 1/6

Trident Texofab has been growing earnings at an average annual rate of 18.6%, while the Retail Distributors industry saw earnings growing at 27.8% annually. Revenues have been growing at an average rate of 12.8% per year. Trident Texofab's return on equity is 1.3%, and it has net margins of 0.6%.

Key information

18.57%

Earnings growth rate

14.24%

EPS growth rate

Retail Distributors Industry Growth21.58%
Revenue growth rate12.77%
Return on equity1.27%
Net Margin0.60%
Last Earnings Update31 Mar 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Trident Texofab makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:540726 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 261,1807280
31 Dec 251,22732330
30 Sep 251,28630290
30 Jun 251,24428290
31 Mar 251,22125290
31 Dec 241,14019280
30 Sep 241,05322280
30 Jun 241,02119270
31 Mar 2499511270
31 Dec 2393612280
30 Sep 2395118280
30 Jun 2396119270
31 Mar 2396422280
31 Dec 2296628270
30 Sep 2295918280
30 Jun 2292811260
31 Mar 2284310250
31 Dec 217899240
30 Sep 216909240
30 Jun 2163610230
31 Mar 214994210
31 Dec 205321250
30 Sep 205922250
30 Jun 206602210
31 Mar 209109260
31 Dec 191,0039260
30 Sep 1997110260
30 Jun 1992412240
31 Mar 1986913220
31 Dec 1880012150
30 Sep 1888111120
30 Jun 18884890
31 Mar 18855880
31 Mar 17759370
31 Mar 16660190

Quality Earnings: 540726 has a large one-off loss of ₹11.3M impacting its last 12 months of financial results to 31st March, 2026.

Growing Profit Margin: 540726's current net profit margins (0.6%) are lower than last year (2.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 540726's earnings have grown by 18.6% per year over the past 5 years.

Accelerating Growth: 540726's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 540726 had negative earnings growth (-71.9%) over the past year, making it difficult to compare to the Retail Distributors industry average (18.5%).


Return on Equity

High ROE: 540726's Return on Equity (1.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/14 03:18
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Trident Texofab Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.